MX2017010710A - Composición terapeútica y profiláctica producida por microbiota. - Google Patents

Composición terapeútica y profiláctica producida por microbiota.

Info

Publication number
MX2017010710A
MX2017010710A MX2017010710A MX2017010710A MX2017010710A MX 2017010710 A MX2017010710 A MX 2017010710A MX 2017010710 A MX2017010710 A MX 2017010710A MX 2017010710 A MX2017010710 A MX 2017010710A MX 2017010710 A MX2017010710 A MX 2017010710A
Authority
MX
Mexico
Prior art keywords
microbiota
therapeutic
composition produced
prophylactic composition
medium
Prior art date
Application number
MX2017010710A
Other languages
English (en)
Inventor
Midtvedt Tore
Raa Jan
Berstad Arnold
Hans Ake Ben DAHLGREN Atti-la
Original Assignee
Invest Sa Neuchatel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Invest Sa Neuchatel filed Critical Invest Sa Neuchatel
Publication of MX2017010710A publication Critical patent/MX2017010710A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/02—Separating microorganisms from their culture media
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Transplantation (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

La invención se relaciona a una composición bioquímica obtenida después de separar los microbios y materia sólida y fibrosa de un ecosistema microbiano (=microbiota) eliminando los microorganismos de un medio de crecimiento en el que la microbiota intestinal y/o las heces se han cultivado anaeróbicamente y liberado del medio de la microbiota y el uso de éstos como un farmacéutico y para el tratamiento o profilaxis de enfermedades.
MX2017010710A 2015-02-19 2016-02-16 Composición terapeútica y profiláctica producida por microbiota. MX2017010710A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE1550189A SE1550189A1 (en) 2015-02-19 2015-02-19 Therapeutic and prophylactic composition produced by microbiota
PCT/SE2016/050119 WO2016133450A1 (en) 2015-02-19 2016-02-16 Therapeutic and prophylactic composition produced by microbiota

Publications (1)

Publication Number Publication Date
MX2017010710A true MX2017010710A (es) 2018-06-07

Family

ID=55646830

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017010710A MX2017010710A (es) 2015-02-19 2016-02-16 Composición terapeútica y profiláctica producida por microbiota.

Country Status (12)

Country Link
US (1) US20180243350A1 (es)
EP (1) EP3258947A1 (es)
JP (1) JP2018511570A (es)
KR (1) KR20170118828A (es)
CN (1) CN107249610A (es)
BR (1) BR112017017805A2 (es)
CA (1) CA2977217A1 (es)
IL (1) IL254016A0 (es)
MX (1) MX2017010710A (es)
SE (1) SE1550189A1 (es)
SG (1) SG11201706768PA (es)
WO (1) WO2016133450A1 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ899700A0 (en) 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
BR112013002667B1 (pt) 2010-08-04 2020-02-04 Thomas Julius Borody composições para transplante da flora intestinal e métodos para fazê-las e usá-las e dispositivos para administrá-las
WO2012122478A1 (en) 2011-03-09 2012-09-13 Regents Of The University Of Minnesota Compositions and methods for transplantation of colon microbiota
NZ737786A (en) 2015-05-22 2022-07-01 Univ Minnesota Methods for treating autism spectrum disorder and associated symptoms
US20170360848A1 (en) 2016-06-15 2017-12-21 Arizona Board Of Regents On Behalf Of Arizona State University Methods for treating autism spectrum disorder and associated symptoms
WO2018071537A1 (en) * 2016-10-11 2018-04-19 Crestovo Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
WO2018071532A1 (en) * 2016-10-11 2018-04-19 Crestovo Holdings Llc Compositions and methods for treating chronic fatigue syndrome and related disorders
US10092601B2 (en) 2016-10-11 2018-10-09 Crestovo Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
WO2018071536A1 (en) 2016-10-11 2018-04-19 Crestovo Holdings Llc Compositions and methods for treating primary sclerosing cholangitis and related disorders
US11040073B2 (en) 2017-04-05 2021-06-22 Finch Therapeutics Holdings Llc Compositions and methods for treating diverticulitis and related disorders
JP2020513018A (ja) 2017-04-05 2020-04-30 クレストヴォ・ホールディングス・エルエルシー パーキンソン病（ｐｄ）および関連する障害を治療するための組成物および方法
US11890306B2 (en) 2017-05-26 2024-02-06 Finch Therapeutics Holdings Llc Lyophilized compositions comprising fecal microbe-based therapeutic agents and methods for making and using same
IL283973B (en) * 2017-06-14 2022-08-01 4D Pharma Res Ltd Preparations containing bacterial strains
WO2019032573A1 (en) 2017-08-07 2019-02-14 Finch Therapeutics, Inc. COMPOSITIONS AND METHODS FOR MAINTAINING AND RESTORING A HEALTHY INTESTINAL BARRIER
KR102218992B1 (ko) * 2017-12-12 2021-02-23 한국생명공학연구원 아가토바쿨룸 속 균주를 유효성분으로 함유하는 자폐 범주성 장애의 예방, 개선 또는 치료용 조성물
CN112074283A (zh) * 2018-02-06 2020-12-11 伊夫罗生物科学公司 使用韦荣氏球菌属细菌治疗癌症和免疫病症的组合物和方法
KR20230049752A (ko) * 2018-02-28 2023-04-13 신바이오시스 가부시키가이샤 생체 미생물 함유 조성물 및 그의 제조 방법
US11166990B2 (en) 2018-07-13 2021-11-09 Finch Therapeutics Holdings Llc Methods and compositions for treating ulcerative colitis
CA3114423A1 (en) 2018-09-27 2020-04-02 Finch Therapeutics Holdings Llc Compositions and methods for treating epilepsy and related disorders
WO2020076043A1 (ko) * 2018-10-08 2020-04-16 한국생명공학연구원 우울증의 예방 또는 치료 효과를 가지는 장내 미생물 및 이의 용도
CN113005061A (zh) * 2020-08-11 2021-06-22 刘树林 具有抗癌活性的厚壁菌门细菌菌株及其抗癌用途
CN112852682A (zh) * 2020-08-11 2021-05-28 刘树林 与芽孢杆菌属近缘的厚壁菌门细菌菌株及其抗癌应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0916335D0 (en) 2009-09-17 2009-10-28 Martin W J Medicaments
CN102711819A (zh) * 2009-09-23 2012-10-03 托马斯·朱利叶斯·波洛迪 肠道感染疗法
WO2011151941A1 (ja) * 2010-06-04 2011-12-08 国立大学法人東京大学 制御性ｔ細胞の増殖または集積を誘導する作用を有する組成物
US20140363397A1 (en) * 2011-09-14 2014-12-11 Queen's University At Kingston Method for treatment of disorders of the gastrointestinal system
LT2750682T (lt) * 2011-10-11 2016-10-10 Achim Biotherapeutics Ab Kompozicija, apimanti anaerobiškai auginamą žmogaus žarnyno mikroflorą
EP2922555A4 (en) * 2012-11-26 2016-06-15 Borody Thomas J COMPOSITIONS FOR THE RESTORATION OF AN FECAL MICROBIOTE AND METHODS OF MAKING AND USING THEM
EP3107553B1 (en) * 2014-02-18 2021-12-01 Universitätsklinikum Jena Methods and compositions for intestinal microenvironment transfer

Also Published As

Publication number Publication date
BR112017017805A2 (pt) 2018-04-10
JP2018511570A (ja) 2018-04-26
CA2977217A1 (en) 2016-08-25
US20180243350A1 (en) 2018-08-30
CN107249610A (zh) 2017-10-13
WO2016133450A1 (en) 2016-08-25
SE1550189A1 (en) 2016-08-20
SG11201706768PA (en) 2017-09-28
IL254016A0 (en) 2017-10-31
EP3258947A1 (en) 2017-12-27
KR20170118828A (ko) 2017-10-25

Similar Documents

Publication Publication Date Title
MX2017010710A (es) Composición terapeútica y profiláctica producida por microbiota.
AR106800A1 (es) Composiciones que comprenden cepas bacterianas
MX2021006581A (es) Bacterias modificadas para tratar enfermedades asociadas con hiperamonemia.
NZ734714A (en) Methods of purifying cannabinoids, compositions and kits thereof
WO2015148863A3 (en) Crispr/cas-related methods and compositions for treating sickle cell disease
WO2016183532A8 (en) Bacteria engineered to treat a disease or disorder
MX2017013562A (es) Reguladores de microbioma y usos relacionados de los mismos.
MX2016014807A (es) Singenes de alfa(1,2)fucosiltransferasa para su utilizacion en la produccion de oligosacaridos fucosilados.
MY188541A (en) Besifloxacin for the treatment of resistant acne
PL3686211T3 (pl) Sposób skutecznego oczyszczania neutralnych oligosacharydów mleka ludzkiego (hmos) z fermentacji mikrobiologicznej
GB2541571A (en) Pharmaceutical compositions
MX2017004904A (es) Cuerpo de planta injertada y método para producirlo.
WO2016210384A3 (en) Bacteria engineered to treat metabolic diseases
EP3474861A4 (en) COMPOUNDS COMPRISING HMOS FOR THE PREVENTION AND / OR TREATMENT OF VIRAL AND / OR BACTERIAL INFECTIONS.
WO2017139697A8 (en) Bacteria engineered to treat diseases associated with hyperammonemia
EP3238745A4 (en) CELL TODINDUCATING AGENT, CYTOSTATIC AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ILLNESSES THROUGH ABNORMAL CELL GROWTH
EP3205713A4 (en) Method for culturing 1,4-dioxane-decomposing bacteria, culture medium, and 1,4-dioxane treatment method using 1,4-dioxane-decomposing bacteria
EP3187579A4 (en) Composition, support, wastewater treatment system, wastewater treating method, deodorization method, and batch wastewater treating method
EP3268010A4 (en) Compositions and methods for treating bacterial infection
MX2017012073A (es) Compuestos de minociclina para biodefensas.
EP3704165A4 (en) MICRO-ORGANISMS FOR WASTE TREATMENT
MX2018005987A (es) Compuestos heterociclicos para el tratamiento de enfermedades.
EP3513856A4 (en) DISPERSION FOR WATER PURIFICATION AND METHOD FOR MANUFACTURING SAME, AND METHOD FOR TREATING WASTEWATER
WO2017123610A3 (en) Bacteria engineered to detoxify deleterious molecules
EP3195870A4 (en) Agent for promoting growth of nonpathogenic oral indigenous bacteria or agent for improving oral bacterial flora, and composition for oral use